logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Lapatinib too toxic in HER2+ gastroesophageal adenocarcinoma

First phase 2 randomized trial of add-on lapatinib with perioperative chemotherapy.